Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment-Reference-Cited by-同舟云学术

Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment

Published:2007 Issue:6 Volume:144B Page:809-815
ISSN:1552-4841
Container-title:American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Dolžan Vita,Plesničar Blanka Kores,Serretti Alessandro,Mandelli Laura,Zalar Bojan,Koprivšek Jure,Breskvar Katja

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Genetics (clinical)

Reference70 articles.

1. , . 2005. Genetics and epigenetics in major psychiatric disorders: Dilemmas, achievements, applications, and future scope. pp. 149–60.

2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th Edition. Washington, DC: American Psychiatric Association.

3. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

4. Association between clozapine response and allelic variation in 5-HT2A receptor gene

5. Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solubility measurements and molecular dynamics simulations of perphenazine (form I) in three binary solvent systems;The Journal of Chemical Thermodynamics;2024-06

2. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders;Signal Transduction and Targeted Therapy;2023-05-03

3. Solubility, MD simulation, thermodynamic properties and solvent effect of perphenazine (Form I) in eleven neat organic solvents ranged from 278.15 K to 318.15 K;Journal of Molecular Liquids;2022-02

4. Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies;Frontiers in Pharmacology;2022-01-24

5. Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients;Biomedicines;2021-07-23